Ostatní
Návod 
OptimizeRx Corporation
OPRX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.3B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
0%
ROA
0%
PE
4593
PS
1
Cena 1R
4-22
⌀ Cena
14.37
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
11-03-2026
Poslední dividenda
Profil
Společnost OptimizeRx Corporation, společnost zabývající se digitálními zdravotnickými technologiemi, poskytuje různá řešení organizacím zabývajícím se vědami o živé přírodě, poskytovatelům zdravotní péče a pacientům. Produkty a aplikace společnosti zahrnují finanční zprávy, virtuální centrum podpory pacientů, které lékařům a zaměstnancům umožňuje přístup k ukázkovým poukázkám, spoluplacení kupónů a další podporu pacientů prostřednictvím jejich EMR a/nebo e-recept systémů; a služby pro informování o značce a terapeutickou podporu zpráv, jako jsou zprávy o povědomí o značce, reklamy na připomenutí a terapeutická podpora a neznačkové zprávy. Nabízí také služby podpory značky, které se zaměřují na vzdělávání a spolupráci s výrobci léčiv na identifikaci, formulování a implementaci mediálních strategií eRx, včetně integrace souborů léků, školení prodejců a služeb rozvoje strategie pro propagaci jejich produktů. Kromě toho společnost provozuje cloudovou platformu Mobile Health Messenger, která poskytuje interaktivní zdravotnické zprávy pro lepší dodržování medikace a koordinaci péče; a automatizovanou platformu pro mobilní zprávy kompatibilní s HIPAA, která umožňuje farmaceutickým výrobcům a souvisejícím subjektům přímo spolupracovat s pacienty na zlepšení dodržování režimu. Dále nabízí programy pro pacienty s informacemi o léčbě a cenové dostupnosti, o životním stylu a sledování stavu, připojení internetových zařízení, formuláře a průzkumy. Kromě toho společnost poskytuje řešení praktické angažovanosti založené na důkazech aplikované na reálná data, aby pomohla poskytovatelům zdravotní péče identifikovat pacienty, kteří mohou být kvalifikováni pro konkrétní terapie, zvýšit povědomí o cestách přístupu pacientů a identifikovat včasné ukazatele nedodržování mezi populacemi pacientů. Nabízí také pracovní postup při zahájení léčby zaměřený na urychlení přístupu pacientů k léčbě, kde je vyžadována časově náročná lékařská dokumentace HCP před tím, než lékárny vydají předepsané léky. Společnost byla založena v roce 2006 a sídlí v Rochesteru v Michiganu.
Sektor
Healthcare
Odvětví
Medical - Healthcare Information Services
Počet zaměstnanců
128
Založení
2007-11-28
Podobné společnosti
$ 17.43
+ $ 0.30
$ 4.45
+ $ 0.08
$ 14.67
- $ 0.03
$ 2.90
- $ 0.04
$ 9.91
+ $ 0.54
$ 13.40
- $ 0.05
$ 28.26
+ $ 0.66
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 109.4 | 109.4 | 92.1 | 71.5 | 62.5 | 61.3 | 43.3 | 24.6 | 21.2 | 12.1 | 7.8 | 7.2 | 6.5 | 5.0 | 2.0 | 1.1 | 0.1 | |
| Cost of Revenues | 40.2 | 40.2 | 32.7 | 28.6 | 23.5 | 25.7 | 19.2 | 9.2 | 9.0 | 6.2 | 3.4 | 3.6 | 3.2 | 1.8 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 69.3 | 69.3 | 59.4 | 42.9 | 39.0 | 35.6 | 24.1 | 15.4 | 12.2 | 6.0 | 4.3 | 3.6 | 3.3 | 3.2 | 2.0 | 1.1 | 0.1 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 32.2 | 26.1 | 29.2 | 21.9 | 32.3 | 21.3 | 18.8 | 19.7 | 28.4 | 16.3 | |
| Cost of Revenues | 12.5 | 8.6 | 10.6 | 8.6 | 10.3 | 7.9 | 7.1 | 7.5 | 10.5 | 6.5 | |
| Gross Profit | 19.8 | 17.5 | 18.6 | 13.3 | 22.0 | 13.4 | 11.7 | 12.2 | 17.8 | 9.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 2.7 | 0.7 | 1.0 | 0.4 | 0.3 | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 53.7 | 49.2 | 33.2 | 24.2 | 17.9 | 11.7 | 7.8 | 5.2 | 3.3 | 3.5 | 2.8 | 2.2 | 2.6 | 1.7 | |
| Depreciation & Amortization | 4.3 | 4.3 | 4.3 | 2.4 | 2.0 | 2.0 | 2.0 | 1.9 | 0.3 | 0.3 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | |
| Total Operating Expenses | 57.2 | 57.2 | 73.1 | 69.3 | 51.3 | 35.3 | 26.2 | 19.1 | 12.0 | 8.1 | 5.9 | 4.2 | 3.9 | 3.0 | 2.4 | 2.6 | 1.9 | |
| Operating Income | 12.1 | 12.1 | -13.7 | -26.4 | -12.3 | 0.5 | -1.9 | -3.7 | 0.2 | -2.1 | -1.6 | -0.6 | -1.0 | 0.2 | -0.4 | -1.5 | -1.8 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 18.9 | 12.9 | ||
| Depreciation & Amortization | 1.2 | 0.9 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.0 | 0.5 | ||
| Total Operating Expenses | 10.8 | 15.5 | 15.4 | 15.5 | 18.4 | 22.0 | 15.5 | 17.2 | 19.9 | 13.4 | ||
| Operating Income | 8.9 | 2.0 | 3.2 | -2.1 | 3.6 | -8.6 | -3.7 | -5.0 | -10.9 | -3.6 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.4 | 0.4 | 0.3 | 2.2 | 0.9 | 0.0 | 0.1 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 5.3 | 5.3 | 6.2 | 1.5 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | 0.1 | |
| Other Expense | -5.1 | -5.1 | -5.7 | 1.2 | 0.9 | -0.1 | -0.3 | -0.3 | -0.6 | 0.0 | -0.1 | 0.0 | -0.4 | 0.0 | 0.0 | 0.3 | -0.1 | |
| IBT | 6.9 | 7.0 | -19.4 | -25.2 | -11.4 | 0.4 | -2.2 | -4.0 | 0.2 | -2.1 | -1.5 | -0.6 | -1.0 | 0.2 | -0.4 | -2.1 | -2.0 | |
| Income Tax Expense | 1.8 | 1.8 | 0.7 | -7.6 | -0.9 | 0.1 | 0.2 | -0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | 0.2 | |
| Net Income | 5.1 | 5.1 | -20.1 | -17.6 | -10.6 | 0.3 | -2.4 | -3.1 | 0.2 | -2.1 | -1.5 | -0.6 | -1.0 | 0.2 | -0.4 | -2.1 | -2.0 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.7 | ||
| Interest Expense | 1.2 | 1.2 | 1.6 | 1.3 | 1.6 | 1.5 | 1.5 | 1.5 | 1.5 | 0.0 | ||
| Other Expense | -1.5 | -1.0 | -1.5 | -1.2 | -1.4 | -1.4 | -1.3 | -1.5 | -0.8 | 0.7 | ||
| IBT | 7.5 | 1.0 | 1.7 | -3.3 | 2.2 | -9.9 | -5.1 | -6.6 | -11.7 | -2.9 | ||
| Income Tax Expense | 2.5 | 0.3 | 0.2 | -1.1 | 2.3 | -0.8 | -1.1 | 0.3 | -7.6 | 0.0 | ||
| Net Income | 5.0 | 0.8 | 1.5 | -2.2 | -0.1 | -9.1 | -4.0 | -6.9 | -4.1 | -2.9 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.03 | $-0.60 | $0.02 | $-0.16 | $-0.23 | $0.02 | $-0.21 | $-0.16 | $-0.07 | $-0.14 | $-0.06 | $-0.08 | $-0.46 | $-0.46 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.03 | $-0.60 | $0.02 | $-0.16 | $-0.23 | $0.02 | $-0.21 | $-0.16 | $-0.07 | $-0.14 | $-0.06 | $-0.08 | $-0.46 | $-0.46 | |
| Shares Outstanding | 18.7 | 18.6 | 18.3 | 17.1 | 17.8 | 17.2 | 14.8 | 13.4 | 10.8 | 9.8 | 9.9 | 8.2 | 7.5 | 4.8 | 4.7 | 4.6 | 4.4 | |
| Diluted Shares Outstanding | 19.4 | 19.0 | 18.3 | 17.1 | 17.8 | 17.7 | 14.8 | 13.4 | 11.9 | 9.8 | 9.9 | 8.2 | 7.5 | 7.1 | 4.7 | 4.6 | 4.4 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.23 | $-0.17 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.23 | $-0.17 | ||
| Shares Outstanding | 18.7 | 18.5 | 18.5 | 18.5 | 18.4 | 18.3 | 18.3 | 18.2 | 18.2 | 16.6 | ||
| Diluted Shares Outstanding | 19.4 | 19.0 | 19.0 | 18.5 | 18.4 | 18.3 | 18.3 | 18.2 | 18.2 | 16.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 15.0 | 13.4 | 13.9 | 18.2 | 84.7 | 10.5 | 18.9 | 8.9 | 5.1 | 7.0 | 8.2 | 3.4 | 1.1 | 0.3 | 1.0 | 1.3 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 55.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 15.0 | 13.4 | 13.9 | 74.1 | 84.7 | 10.5 | 18.9 | 8.9 | 5.1 | 7.0 | 8.2 | 3.4 | 1.1 | 0.3 | 1.0 | 1.3 | |
| Accounts Receivable | 26.4 | 38.2 | 37.3 | 22.2 | 24.8 | 17.9 | 7.4 | 6.5 | 3.4 | 3.1 | 2.8 | 2.1 | 1.6 | 0.6 | 0.5 | 0.2 | |
| Inventory | 0.0 | 0.0 | 0.0 | 1.8 | -5,630,649.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Other Current Assets | 4.6 | 2.4 | 2.8 | 0.5 | 5,630,655.0 | 4.5 | 0.9 | 0.6 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.5 | |
| Total Current Assets | 46.0 | 54.0 | 54.3 | 98.6 | 115.1 | 32.9 | 27.1 | 16.0 | 8.8 | 10.2 | 11.1 | 5.6 | 2.7 | 1.0 | 1.6 | 2.1 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 19.5 | 16.6 | 16.6 | 13.4 | 16.1 | 15.0 | 15.2 | 13.9 | 9.9 | 9.8 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 53.6 | 52.9 | |
| Total Cash & ST Investments | 19.5 | 16.6 | 16.6 | 13.4 | 16.1 | 15.0 | 15.2 | 13.9 | 63.5 | 62.7 | |
| Accounts Receivable | 32.2 | 34.2 | 32.8 | 38.2 | 26.4 | 26.4 | 30.8 | 37.3 | 20.8 | 18.3 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 4.6 | 3.3 | 2.3 | 2.4 | 4.4 | 4.6 | 2.4 | 3.2 | 3.0 | 4.1 | |
| Total Current Assets | 56.3 | 54.1 | 51.7 | 54.0 | 46.9 | 46.0 | 48.4 | 54.3 | 87.4 | 85.1 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 0.6 | 0.5 | 0.7 | 0.4 | 0.5 | 0.6 | 0.7 | 0.1 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Goodwill | 78.4 | 70.9 | 78.4 | 22.7 | 14.7 | 14.7 | 14.7 | 3.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 47.5 | 45.5 | 49.4 | 13.0 | 10.6 | 12.1 | 13.9 | 5.3 | 0.8 | 1.1 | 1.2 | 1.4 | 1.3 | 1.2 | 1.3 | 1.2 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.4 | 0.3 | 0.6 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | |
| Total Long-Term Assets | 126.9 | 117.2 | 129.0 | 36.1 | 25.9 | 27.5 | 29.5 | 9.1 | 1.0 | 1.3 | 1.2 | 1.5 | 1.3 | 1.2 | 1.3 | 1.7 | |
| Total Assets | 172.9 | 171.2 | 183.4 | 134.7 | 141.0 | 60.3 | 56.6 | 25.1 | 9.8 | 11.5 | 12.3 | 7.0 | 4.0 | 2.2 | 2.9 | 3.7 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 0.6 | 0.7 | 0.5 | 0.5 | 0.6 | 0.6 | 0.7 | 0.7 | 0.3 | 0.2 | |
| Goodwill | 70.9 | 70.9 | 70.9 | 70.9 | 70.9 | 78.4 | 78.4 | 78.4 | 22.7 | 22.7 | |
| Intangible Assets | 42.4 | 43.5 | 44.5 | 45.5 | 46.5 | 47.5 | 48.5 | 49.4 | 12.5 | 13.4 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.5 | 0.6 | 1.1 | -36.3 | |
| Total Long-Term Assets | 114.0 | 115.2 | 116.1 | 117.2 | 118.3 | 126.9 | 128.0 | 129.0 | 36.5 | 36.3 | |
| Total Assets | 170.3 | 169.3 | 167.8 | 171.2 | 165.2 | 172.9 | 176.4 | 183.4 | 123.9 | 121.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 3.0 | 2.2 | 2.2 | 5.5 | 5.0 | 5.6 | 2.1 | 2.3 | 2.1 | 3.0 | 3.1 | 2.3 | 2.0 | 0.6 | 0.9 | 0.6 | |
| Short-Term Debt | 3.5 | 2.2 | 2.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.2 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 7.4 | 13.5 | 13.3 | 2.6 | 2.9 | 4.0 | 3.3 | 1.3 | 1.0 | 0.3 | 0.0 | 0.0 | 1.2 | 0.0 | 0.1 | 0.0 | |
| Current Liabilities | 15.0 | 18.7 | 17.9 | 8.4 | 9.4 | 10.0 | 6.1 | 4.2 | 3.5 | 3.7 | 3.4 | 2.4 | 2.0 | 0.7 | 1.3 | 0.9 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 2.0 | 2.0 | 3.4 | 2.2 | 2.8 | 3.0 | 1.7 | 2.2 | 0.7 | 0.8 | |
| Short-Term Debt | 3.5 | 3.5 | 3.4 | 2.2 | 2.2 | 3.5 | 3.7 | 2.2 | 0.1 | 0.0 | |
| Other Current Liabilities | 12.9 | 15.1 | 11.0 | 13.5 | 8.8 | 7.4 | 10.1 | 13.3 | 6.8 | 4.2 | |
| Current Liabilities | 18.5 | 21.1 | 18.4 | 18.7 | 14.5 | 15.0 | 16.8 | 17.9 | 7.7 | 5.5 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 32.3 | 31.0 | 34.6 | 0.1 | 0.2 | 0.3 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 0.3 | 0.4 | 0.6 | 0.2 | 0.3 | 0.4 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 4.3 | 4.5 | 4.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 51.9 | 54.2 | 56.8 | 8.5 | 9.6 | 10.4 | 11.8 | 6.6 | 3.5 | 3.7 | 3.4 | 2.4 | 2.0 | 0.7 | 1.3 | 1.9 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 25.1 | 25.5 | 29.4 | 31.0 | 33.5 | 32.6 | 32.7 | 34.6 | 0.1 | 0.0 | |
| Capital Leases | 0.5 | 0.5 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.1 | 0.0 | |
| Def. Tax Liability | 0.0 | 3.5 | 3.8 | 4.5 | 2.7 | 4.3 | 4.3 | 4.3 | 0.0 | 0.0 | |
| Total Liabilities | 48.1 | 50.0 | 51.5 | 54.2 | 50.7 | 51.9 | 53.8 | 56.8 | 7.8 | 5.5 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -75.2 | -84.4 | -64.3 | -46.7 | -35.3 | -35.6 | -33.4 | -30.3 | -30.4 | -28.3 | -26.7 | -26.1 | -24.6 | -24.7 | -24.4 | -21.8 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 121.0 | 117.0 | 126.6 | 126.1 | 131.4 | 50.0 | 44.9 | 18.5 | 6.2 | 7.8 | 8.9 | 4.6 | 2.0 | 1.5 | 1.6 | 1.9 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -84.3 | -85.0 | -86.6 | -84.4 | -84.3 | -75.2 | -71.2 | -64.3 | -60.1 | -57.3 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 122.3 | 119.3 | 116.3 | 117.0 | 114.5 | 121.0 | 122.5 | 126.6 | 116.1 | 115.8 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 36.1 | 33.2 | 36.8 | 0.2 | 0.3 | 0.4 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 121.0 | 117.0 | 126.6 | 126.1 | 131.4 | 50.0 | 44.9 | 18.5 | 6.2 | 7.8 | 8.9 | 4.6 | 2.0 | 1.5 | 1.6 | 1.9 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 122.3 | 119.3 | 116.3 | 117.0 | 114.5 | 121.0 | 122.5 | 126.6 | 116.1 | 115.8 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -17.9 | 5.1 | -20.1 | -17.6 | -11.4 | 0.4 | -2.2 | -3.1 | 0.2 | -2.1 | -1.5 | -0.6 | -1.0 | 0.2 | -0.4 | -2.1 | -2.0 | |
| Depreciation & Amortization | 3.6 | 4.3 | 4.3 | 2.4 | 2.0 | 2.0 | 2.0 | 1.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | |
| Stock-Based Compensation | 11.8 | 7.0 | 11.5 | 13.7 | 15.7 | 5.5 | 3.2 | 2.3 | 1.9 | 0.1 | 0.2 | 0.3 | 0.9 | 0.4 | 0.2 | 0.2 | 0.5 | |
| Change Working Capital | -9.4 | 0.8 | 0.9 | -15.5 | 4.0 | -7.3 | -9.7 | -1.8 | -2.3 | -0.7 | 0.3 | 0.2 | -0.5 | 0.3 | -0.7 | 0.2 | 0.0 | |
| Change In Accounts Receivable | -0.7 | 0.5 | -2.2 | -8.7 | 2.3 | -7.0 | -10.7 | -0.5 | -2.8 | -0.4 | -0.2 | -0.7 | -0.6 | -1.0 | -0.2 | -0.2 | -0.2 | |
| Change In Accounts Payable | 1.1 | -0.5 | -0.1 | -1.3 | 0.6 | -0.6 | 3.5 | -0.3 | 0.6 | -0.9 | 0.1 | 0.9 | 0.2 | 1.2 | -0.3 | 0.3 | 0.0 | |
| Change In Inventories | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | -0.8 | -2.2 | -0.9 | -0.1 | 0.5 | 0.3 | -0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 7,703.2 | 0.3 | 6.8 | 9.8 | 0.4 | 0.1 | 0.2 | 0.6 | 0.7 | 0.8 | 0.4 | 0.3 | 0.3 | 0.0 | 0.1 | 0.2 | 0.0 | |
| Cash from Operations | -1.9 | 0.0 | 0.0 | -7.2 | 10.7 | 0.7 | -6.3 | -1.7 | 0.8 | -1.5 | -0.5 | 0.5 | -0.1 | 1.1 | -0.6 | -0.5 | -1.3 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 5.0 | 0.8 | 1.5 | -2.2 | -0.1 | -9.1 | -4.0 | -6.9 | -4.1 | -2.9 | |
| Depreciation & Amortization | 1.1 | 1.3 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.0 | 0.5 | |
| Stock-Based Compensation | 2.0 | 2.0 | 1.5 | 1.6 | 2.9 | 2.6 | 2.9 | 3.0 | 2.6 | 3.2 | |
| Change Working Capital | -1.7 | -0.7 | 0.0 | 3.2 | -5.5 | -5.2 | 0.6 | 4.6 | -15.0 | 0.4 | |
| Change In Accounts Receivable | -3.5 | 1.3 | -1.3 | 5.5 | -12.9 | -1.8 | 5.2 | 6.4 | -9.6 | -2.8 | |
| Change In Accounts Payable | -0.4 | 0.0 | -1.4 | -2.1 | -0.6 | -0.2 | 1.3 | -0.6 | -0.5 | 0.8 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.0 | 2.6 | |
| Other Non-cash Items | -0.5 | -0.1 | 0.8 | 0.2 | 0.1 | 14.1 | 0.2 | 0.3 | 7,704.7 | 0.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.3 | 1.5 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.2 | -0.1 | -0.1 | -0.1 | -0.2 | -0.5 | -0.1 | -1.6 | -0.1 | 0.0 | -0.3 | -0.1 | -0.4 | -0.3 | -0.1 | -0.2 | -0.2 | |
| Acquisitions | -80.1 | 0.0 | 0.0 | -82.9 | -2.0 | 0.0 | 0.0 | -9.0 | -5.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -162,668.0 | 0.0 | 0.0 | -162.8 | -55.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 106.2 | 0.0 | 0.0 | 218.7 | 2,163.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 162,614.3 | 0.0 | 0.0 | 1.8 | -2,163.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -27.2 | 0.0 | 0.0 | -25.3 | -58.2 | -0.5 | -0.1 | -10.6 | -5.7 | 0.0 | -0.3 | -0.1 | -0.4 | -0.3 | -0.1 | -0.2 | -0.2 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.8 | -0.3 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -80.4 | 0.3 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -162,614.7 | -53.3 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 53.6 | 52.6 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 162,614.7 | -0.3 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -26.0 | -1.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -37.0 | 0.0 | 0.0 | 36.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.0 | 0.0 | |
| Debt Issued | 73.1 | 33.2 | -3.6 | 72.6 | -0.1 | -0.1 | -0.1 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | 0.0 | |
| Issuance of Common Stock | -0.1 | 0.0 | 0.0 | 0.0 | 70,671.5 | 70.7 | 0.0 | 21.3 | 8.2 | 0.0 | 0.4 | 4.3 | 8.8 | 0.2 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -0.5 | 0.0 | -0.9 | -7.8 | -20.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | -0.8 | 0.0 | -6.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -0.3 | 0.0 | 0.0 | 0.0 | -70,670.5 | 3.3 | -1.9 | 0.9 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | 1.4 | 2.2 | |
| Cash from Financing | 34.3 | 0.0 | 0.0 | 28.2 | -19.0 | 73.9 | -1.9 | 22.2 | 8.7 | -0.4 | -0.4 | 4.3 | 2.8 | 0.2 | 0.0 | 0.4 | 2.2 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 28.6 | -0.4 | -3.8 | -0.4 | -2.5 | -0.4 | -0.4 | -0.4 | 36.7 | 0.1 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | |
| Repurchase of Common Stock | 0.0 | -0.1 | 0.0 | -0.1 | -0.3 | 0.0 | -0.4 | -0.1 | -0.3 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 36.2 | -0.3 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 36.2 | -0.3 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 5.2 | 10.0 | -0.5 | -4.4 | -66.5 | 74.2 | -8.3 | 9.9 | 3.8 | -1.9 | -1.2 | 4.8 | 2.3 | 0.8 | -0.7 | -0.3 | 0.6 | |
| Closing Cash Balance | 15.0 | 23.4 | 13.4 | 13.9 | 18.2 | 84.7 | 10.5 | 18.9 | 8.9 | 5.1 | 7.0 | 8.2 | 3.4 | 1.1 | 0.3 | 1.0 | 1.3 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 3.8 | 2.9 | 0.0 | 3.2 | -2.7 | 1.2 | -0.2 | 1.3 | 3.9 | 0.1 | |
| Closing Cash Balance | 23.4 | 19.5 | 16.6 | 16.6 | 13.4 | 16.1 | 15.0 | 15.2 | 13.9 | 9.9 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.7 | 18.7 | 4.8 | -8.1 | 10.4 | 0.2 | -6.4 | -3.2 | 0.7 | -1.5 | -0.8 | 0.4 | -0.5 | 0.8 | -0.7 | -0.8 | -1.5 | |
| Real Free Cash Flow | -13.4 | 11.7 | -6.7 | -21.8 | -5.3 | -5.3 | -9.6 | -5.5 | -1.2 | -1.6 | -1.0 | 0.1 | -1.4 | 0.4 | -0.9 | -0.9 | -2.0 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 7.1 | 3.2 | 4.6 | 3.8 | 0.1 | 1.7 | 0.7 | 2.0 | -5.5 | 1.2 | |
| Real Free Cash Flow | 5.1 | 1.2 | 3.1 | 2.3 | -2.9 | -0.9 | -2.2 | -1.1 | -8.1 | -2.1 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 4593.2 | 531 | 120.8 |
| P/S | 1.4 | 7.8 | 9.7 |
| P/B | 1.3 | 5 | 738.2 |
| P/FCF | 42 | -256.5 | 111.3 |
| Market cap | $0.3 | $0.4 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 16.8 % | 3.1 % | 0 % |
| Debt to Income | 557.4 % | 1342.8 % | 0 % |
| Debt to Free cash flow | 244.6 % | -2199.3 % | 0 % |
| Interest expense percentage | 43.9 % | 354.2 % | 18.1 % |
| Current ratio | 3 | 5.4 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 4.2 % | 0.4 % | 0 % |
| ROA | 3 % | 8.7 % | 0 % |
| CapEx to Revenue | 0.1 % | 82.2 % | 2.4 % |
| RaD to Revenue | 0 % | 4.7 % | 0 % |
| ROEM | 1,032,349.1 | 389326.2 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 65.3 % | 61.8 % | 89.7 % |
| Operating margin | 6.2 % | -545.7 % | 37.4 % |
| Net margin | 0 % | -501.9 % | 37.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -23.2 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 19.0 mil | 11.4 mil |
| Employee count | 0.1 tis | 0.0 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
